Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic head & neck squamous cell carcinoma - subgroup analysis of the PEVOsq basket trial

被引：0
|
作者：
Le Tourneau, C. [1 ]
Ghiringhelli, F. [2 ]
Saada, E. B. [3 ]
Chaltiel, R. [4 ]
Vansteene, D. [5 ]
Durando, X. [6 ]
You, B. [7 ]
Borel, C. [8 ]
Bigot, F. [9 ]
Abdeddaim, C. [10 ]
Marret, G. [11 ]
Jeannot, E. [12 ]
Rocco, E. Guerini [13 ]
Frige, G. [14 ]
Servant, N. [15 ]
Dupain, C. [16 ]
Kamal, M. [16 ]
Legrand, F. [17 ]
Jimenez, M. [17 ]
Filleron, T. [18 ]
机构：
[1] Inst Curie, Dept Drug Dev & Innovat D3i, Paris, France
[2] Ctr Georges Francois Leclerc Dijon, Med Oncol, Dijon, France
[3] Ctr Anticancer Antoine Lacassagne, Med Oncol, Nice, France
[4] CHU Reims, Hop Robert Debre, Reims, France
[5] ICO Inst Cancerol Ouest Rene Gauducheau, Dept Med Oncol, St Herblain, France
[6] Ctr Jean PERRIN, F-63000 Clermont Ferrand, France
[7] HCL, Ctr Hosp Lyon Sud, Oncol Dept, Pierre Benite, France
[8] Ctr Lutte Canc, Ctr Paul Strauss, Med Oncol Dept, Strasbourg, France
[9] ICO Inst Cancerol Ouest, Dept Med Oncol, Site Paul Papin, Angers, France
[10] Ctr Oscar Lambret, Dept Med Oncol, Lille, France
[11] Inst Curie, Dept Drug Dev & Innovat, Paris, France
[12] Inst Curie, Pathol, Paris, France
[13] IEO Ist Europeo Oncol IRCCS, Dept Med Oncol, Milan, Italy
[14] IEO Ist Europeo Oncol, Expt Oncol, Milan, Italy
[15] Inst Curie, Dept Med Oncol, Paris, France
[16] Inst Curie, Drug Dev & Innovat Dept, Paris, France
[17] UNICANCER, R&D Dept, Paris, France
[18] IUCT Oncopole, Inst Claudius Regaud, Haute Garonne, Toulouse, France
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2067
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
923P
引用
收藏
页码：S583 / S583
页数：1
相关论文
共 50 条
  • [1] Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic anal squamous cell carcinoma: Subgroup analysis of the PEVOsq basket trial
    Coutzac, C.
    Bigot, F.
    Vansteene, D.
    Dos Santos, M.
    Ghiringhelli, F.
    You, B.
    Lambert, A.
    Gomez-Roca, C. A.
    Abdeddaim, C.
    Neuzillet, C.
    Jeannot, E.
    Rocco, E. Guerini
    Frige, G.
    Mazzarella, L.
    Dupain, C.
    Kamal, M.
    Legrand, F.
    Jimenez, M.
    Filleron, T.
    Le Tourneau, C.
    ANNALS OF ONCOLOGY, 2023, 34 : S415 - S415
  • [2] Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic squamous cell carcinoma of the penis: Subgroup analysis of the PEVOsq basket trial
    Coquan, E.
    Gomez-Roca, C. A.
    Lambert, A.
    You, B.
    Vansteene, D.
    Bigot, F.
    Cousin, S.
    Castel Ajgal, Z.
    Jeannot, E.
    Rocco, E. Guerini
    Frige, G.
    Mazzarella, L.
    Francisco, M.
    Servant, N.
    Halladjian, M.
    Kamal, M.
    Legrand, F.
    Jimenez, M.
    Cabarrou, B.
    Le Tourneau, C.
    ANNALS OF ONCOLOGY, 2023, 34 : S1223 - S1223
  • [3] Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic squamous cell cervix carcinoma: Subgroup analysis of the PEVOsq basket trial
    Le Saux, O.
    Borel, C.
    Ghiringhelli, F.
    Bigot, F.
    Vansteene, D.
    Chaltiel, R.
    Cousin, S.
    Durando, X.
    Coquan, E.
    Abdeddaim, C.
    Jeannot, E.
    Rocco, E. Guerini
    Frige, G.
    Francisco, M.
    Halladjian, M.
    Kamal, M.
    Legrand, F.
    Jimenez, M.
    Cabarrou, B.
    Le Tourneau, C.
    ANNALS OF ONCOLOGY, 2023, 34 : S515 - S516
  • [4] Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic vulvar and vaginal squamous cell carcinoma: Subgroup analysis of the PEVOsq basket trial
    Saint-Ghislain, M.
    Abdeddaim, C.
    Chaltiel, R.
    Cousin, S.
    Gomez-Roca, C. A.
    Borel, C.
    Ghiringhelli, F.
    Vansteene, D.
    Bigot, F.
    Jeannot, E.
    Rocco, E. Guerini
    Frige, G.
    Mazzarella, L.
    Francisco, M.
    Legrand, F.
    Jimenez, M.
    Halladjian, M.
    Kamal, M.
    Cabarrou, B.
    Le Tourneau, C.
    ANNALS OF ONCOLOGY, 2023, 34 : S518 - S518
  • [5] Phase II basket trial evaluating the efficacy of pembrolizumab (PE) combined with vorinostat (VO) in patients (pts) with recurrent and/or metastatic squamous cell carcinoma (SCC)
    Le Tourneau, Christophe
    Bigot, Frederic
    Vansteene, Damien
    Kamal, Maud
    Ghiringhelli, Francois
    Mazzarella, Luca
    Borel, Christian
    Chaltiel, Raphael
    You, Benoit
    Gomez-Roca, Carlos A.
    Cousin, Sophie
    Coquan, Elodie
    Lambert, Aure Prime Lien
    Saada-Bouzid, Esma
    Durando, Xavier
    Legrand, Francois
    Lusque, Amellie
    Andre, Fabrice
    Filleron, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer
    Rodriguez, Cristina P.
    Wu, Qian
    Voutsinas, Jenna
    Fromm, Jonathan R.
    Jiang, Xiuyun
    Pillarisetty, Venu G.
    Lee, Sylvia M.
    Santana-Davila, Rafael
    Goulart, Bernardo
    Baik, Christina S.
    Chow, Laura Q. M.
    Eaton, Keith
    Martins, Renato
    CLINICAL CANCER RESEARCH, 2020, 26 (04) : 837 - 845
  • [7] A phase II trial of pembrolizumab and cabozantinib in patients (pts) with recurrent metastatic head and neck squamous cell carcinoma (RMHNSCC).
    Saba, Nabil F.
    Ekpenyong, Asari
    McCook-Veal, Ashley
    Patel, Mihir
    Schmitt, Nicole Cherie
    Stokes, William A.
    Bates, James Edward
    Rudra, Soumon
    Abousaud, Marin Ibrahim
    Muzaffar, Jameel
    Kirtane, Kedar
    Teng, Yong
    Steuer, Conor Ernst
    Shin, Dong Moon
    Liu, Yuan
    Chung, Christine H.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [8] Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial
    Saba, Nabil F.
    Steuer, Conor E.
    Ekpenyong, Asari
    McCook-Veal, Ashley
    Magliocca, Kelly
    Patel, Mihir
    Schmitt, Nicole C.
    Stokes, William
    Bates, James E.
    Rudra, Soumon
    Remick, Jill
    McDonald, Mark
    Abousaud, Marin
    Tan, Aik Choon
    Fadlullah, Muhammad Zaki Hidayatullah
    Chaudhary, Ritu
    Muzaffar, Jameel
    Kirtane, Kedar
    Liu, Yuan
    Chen, Georgia Z.
    Shin, Dong M.
    Teng, Yong
    Chung, Christine H.
    NATURE MEDICINE, 2023, 29 (04) : 880 - 887
  • [9] A phase II trial of vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Saxman, S
    Mann, B
    Canfield, V
    Loehrer, P
    Vokes, E
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (04): : 398 - 400
  • [10] A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Espinosa, E
    Zamora, P
    Millá, A
    Morales, S
    Molina, R
    Mira, M
    Barón, MG
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (12): : 1054 - 1059
12345